Highest-materiality recent filing
Nature's Sunshine Q1 net sales $122.9M (+9% YoY), EPS $0.29 (+16%), adj. EBITDA +33%
Net sales rose 9% to $122.9M (7% constant currency); all regions grew, led by N. America +9%.
Nature's Sunshine Q4 net sales up 4.7% to $123.8M; EPS $0.23 vs ($0.02) YoY
GAAP net income of $4.1M ($0.23 diluted EPS) vs net loss of $0.3M ($0.02 loss) in Q4 2024.
Nature's Sunshine Q3 net sales $128.3M (+12% YoY), EPS $0.30 (+30%), raises FY outlook
GAAP diluted EPS $0.30 vs $0.23 YoY; adjusted EBITDA $15.2M (+42%).
Nature's Sunshine appoints Kenneth Romanzi as CEO effective Oct 29, 2025
Romanzi, former B&G Foods CEO, succeeds Terrence Moorehead who steps down as CEO and board member.
NATR Q2 net sales up 4% to $114.8M; EPS $0.28 vs $0.07; raises FY guidance
GAAP diluted EPS $0.28 ($5.3M net income) vs $0.07 ($1.3M) in Q2 2024.
Fosun Pharma to sell 2.85M NATR shares at $12; company may repurchase up to $15M
Secondary offering of 2,854,607 shares by selling stockholder Fosun Pharma USA at $12.00 per share.
CEO Terrence Moorehead to step down; Board begins search for successor
Terrence Moorehead notified Board on May 28, 2025, of plan to step down as CEO and director once successor appointed.
Nature's Sunshine Q1 net income up 104% to $0.25 EPS; authorizes $25M buyback
GAAP net income $4.7M ($0.25 EPS) vs $2.3M ($0.12) YoY; net sales $113.2M, up 2% (5% constant currency).
Nature's Sunshine Q3 revenue $114.6M (+3% YoY), EPS $0.23; appoints Steven Fasching to board
GAAP net income $4.3M ($0.23 diluted EPS) vs $2.8M ($0.15) a year ago.
Nature's Sunshine Q2 net sales down 5% to $110.6M; cuts FY2024 guidance
GAAP diluted EPS $0.07 vs $0.12 year ago; net income $1.3M down from $2.4M.
Nature's Sunshine Q1 net income $2.3M ($0.12 EPS); digital sales surge 33%
Net sales $111.0M (+2% YoY, +4% constant currency); gross margin 71.2% (+33 bps).
Nature's Sunshine Q4 net income triples to $9.0M; full-year 2023 adjusted EBITDA up 26%
Q4 net sales $108.9M, up 6% YoY; North America sales up 12.8%. GAAP EPS $0.46 vs $0.10.
Nature's Sunshine Q3 net income jumps to $2.8M; adj. EBITDA up 50% to $10.3M; raises FY outlook
Net sales $111.2M, up 6% YoY (7% constant currency); Asia/Pacific +12% local currency, North America +11%.
Nature's Sunshine Q2 net sales up 12% to $116.5M; EPS $0.12 vs $0.03; FY guidance issued
Net sales $116.5M, up 12% YoY (14% constant currency); Asia/Pacific led with 15.8% growth.
Net sales $108.6M, down 1.7% reported, up 2.4% constant currency; Asia segment grew 9.1% constant currency.
Nature's Sunshine Q4 net sales $102.7M (-6.4% cc); GAAP EPS $0.10; FY adjusted EBITDA $32M
Q4 net sales $102.7M, down 6.4% in constant currency vs year-ago; GAAP net income $2.0M ($0.10/sh).
Nature's Sunshine Japan subsidiary loses $4.8M in wire fraud scheme
Synergy Japan victim of employee impersonation fraud; $4.8M transferred between Feb 1-17, 2023.
Nature's Sunshine appoints Shane Jones as CFO; amendment corrects terms
Shane Jones named CFO effective Dec 19, 2022 (amended from Dec 30).
Shane Jones appointed CFO effective December 30, 2022; base salary $430,000, one-time bonus $150,000.
Nature's Sunshine Q3 sales down 8.9% to $104.5M; GAAP EPS $0.00 vs $0.24 YoY
Net sales $104.5M (down 2.3% constant currency) vs $114.7M a year ago.
Nature's Sunshine CFO Joseph Baty to retire Sept 30; Jonathan Lanoy named Interim CFO
CFO Joseph Baty retiring effective September 30, 2022; search for permanent CFO underway.
Nature's Sunshine Q2 net sales $104.2M, GAAP EPS $0.03 vs $0.32; adjusted EBITDA $9.0M
Net sales $104.2M (-4.4% reported, +0.5% constant currency); GAAP EPS $0.03 vs $0.32 a year ago.
Nature's Sunshine Q1 net sales up 8% to record $110.5M; GAAP net loss $(0.15)
Net sales rose 7.9% to a record $110.5M; ex-FX +10.3%.
Q4 net sales record $117.9M (+15.9% YoY); GAAP EPS $0.67 vs $0.29; adjusted EPS $0.68 vs $0.32.
Nature's Sunshine reports record Q3 net sales of $114.7M, up 14% YoY; adj EBITDA up 38% to $12.9M
Net sales record $114.7M, up 14.5% YoY; Asia led with 27.1% growth; Europe up 21.1%.
Nature's Sunshine Q2 2021 net sales record $109M (+25% YoY); Adj. EBITDA record $13.4M (+38%)
Net sales $109.0M (record), +25% YoY; GAAP EPS $0.32 vs $0.29; Adj. EPS $0.32 vs $0.28.
Nature's Sunshine Q3 2020: Record net sales $100.3M (+13% YoY); net income $7.2M vs $1.4M
GAAP net income $7.2M ($0.34 diluted EPS) vs $1.4M ($0.07) a year ago; adjusted EPS also $0.34.
NATR Q2 2020: Net income jumps to $0.29/diluted share; sales slip 3.8%
GAAP net income $5.8M ($0.29/diluted) vs $2.7M ($0.14) year ago; adjusted EPS $0.28.
On May 8, 2026, Mr. Jonathan D. Lanoy was appointed to serve as the Company’s Interim Principal Financial Officer.
On May 8, 2026, L. Shane Jones notified Nature’s Sunshine Products, Inc. (the “Company”) that he is resigning as the Company’s Chief Financial Officer effective June 5, 2026.
On May 28, 2025, Terrence O. Moorehead, the President, Chief Executive Officer and member of the Board of Directors (the “Board”) of Nature’s Sunshine Products, Inc. (the “Company”) notified the Board that he has decided to step down as an officer and resign as a director of the Company, effective upon the appointment by the Company of a successor President and Chief Executive Officer of the Company.
On February 4, 2025, Mr. Richard D. Moss notified the board of his decision to not stand for re-election at the company's upcoming 2025 annual shareholder meeting.
On January 30, 2025, the Company’s Board of Directors appointed Ms. Katie A. May to its Board of Directors.
On November 6, 2024, the Company’s Board of Directors appointed Mr. Steven J. Fasching to its Board of Directors.
Also on January 24, 2023, the Company appointed Mr. Jones to serve as the Company’s Principal Financial Officer.
On January 24, 2023, Mr. Lanoy was appointed Chief Accounting Officer, and will continue to serve as the Company’s Principal Accounting Officer.
On December 6, 2022, Nature’s Sunshine Products, Inc. (the “Company”) issued a press release announcing the hiring of Mr. Shane Jones as the Company’s Executive Vice President, Chief Financial Officer.
On December 6, 2022, Nature’s Sunshine Products, Inc. (the “Company”) issued a press release announcing the hiring of Mr. Shane Jones as the Company’s Executive Vice President, Chief Financial Officer.
The press release also announced the promotion of Mr. Jonathan D. Lanoy to the position of Senior Vice President, Finance effective immediately.
On September 6, 2022, Nature’s Sunshine Products, Inc. (the “Company”) issued a press release announcing that Mr. Joseph W. Baty, the Company’s Executive Vice President, Chief Financial Officer will retire from the Company effective September 30, 2022.
Max materiality 0.85 · Median 0.60 · Most common event earnings